Request for Covid-19 Impact Assessment of this Report
The United States Gastrointestinal Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gastrointestinal Drugs market, reaching US$ million by the year 2028. As for the Europe Gastrointestinal Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gastrointestinal Drugs players cover AstraZeneca, Sanofi, Bayer, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastrointestinal Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gastrointestinal Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gastrointestinal Drugs by Country/Region, 2017, 2022 & 2028
2.2 Gastrointestinal Drugs Segment by Type
2.2.1 Prescription Gastrointestinal Drug
2.2.2 OTC Gastrointestinal Drug
2.3 Gastrointestinal Drugs Sales by Type
2.3.1 Global Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Gastrointestinal Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gastrointestinal Drugs Sale Price by Type (2017-2022)
2.4 Gastrointestinal Drugs Segment by Application
2.4.1 Chronic Gastritis
2.4.2 Functional Dyspepsia
2.4.3 Peptic Ulcer
2.4.4 Acute Gastroenteritis
2.4.5 Other
2.5 Gastrointestinal Drugs Sales by Application
2.5.1 Global Gastrointestinal Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Gastrointestinal Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gastrointestinal Drugs Sale Price by Application (2017-2022)
3 Global Gastrointestinal Drugs by Company
3.1 Global Gastrointestinal Drugs Breakdown Data by Company
3.1.1 Global Gastrointestinal Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Gastrointestinal Drugs Sales Market Share by Company (2020-2022)
3.2 Global Gastrointestinal Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Gastrointestinal Drugs Revenue by Company (2020-2022)
3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Gastrointestinal Drugs Sale Price by Company
3.4 Key Manufacturers Gastrointestinal Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastrointestinal Drugs Product Location Distribution
3.4.2 Players Gastrointestinal Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gastrointestinal Drugs by Geographic Region
4.1 World Historic Gastrointestinal Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Gastrointestinal Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gastrointestinal Drugs Annual Revenue by Geographic Region
4.2 World Historic Gastrointestinal Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Gastrointestinal Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gastrointestinal Drugs Annual Revenue by Country/Region
4.3 Americas Gastrointestinal Drugs Sales Growth
4.4 APAC Gastrointestinal Drugs Sales Growth
4.5 Europe Gastrointestinal Drugs Sales Growth
4.6 Middle East & Africa Gastrointestinal Drugs Sales Growth
5 Americas
5.1 Americas Gastrointestinal Drugs Sales by Country
5.1.1 Americas Gastrointestinal Drugs Sales by Country (2017-2022)
5.1.2 Americas Gastrointestinal Drugs Revenue by Country (2017-2022)
5.2 Americas Gastrointestinal Drugs Sales by Type
5.3 Americas Gastrointestinal Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Drugs Sales by Region
6.1.1 APAC Gastrointestinal Drugs Sales by Region (2017-2022)
6.1.2 APAC Gastrointestinal Drugs Revenue by Region (2017-2022)
6.2 APAC Gastrointestinal Drugs Sales by Type
6.3 APAC Gastrointestinal Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gastrointestinal Drugs by Country
7.1.1 Europe Gastrointestinal Drugs Sales by Country (2017-2022)
7.1.2 Europe Gastrointestinal Drugs Revenue by Country (2017-2022)
7.2 Europe Gastrointestinal Drugs Sales by Type
7.3 Europe Gastrointestinal Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gastrointestinal Drugs by Country
8.1.1 Middle East & Africa Gastrointestinal Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gastrointestinal Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Gastrointestinal Drugs Sales by Type
8.3 Middle East & Africa Gastrointestinal Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastrointestinal Drugs
10.3 Manufacturing Process Analysis of Gastrointestinal Drugs
10.4 Industry Chain Structure of Gastrointestinal Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastrointestinal Drugs Distributors
11.3 Gastrointestinal Drugs Customer
12 World Forecast Review for Gastrointestinal Drugs by Geographic Region
12.1 Global Gastrointestinal Drugs Market Size Forecast by Region
12.1.1 Global Gastrointestinal Drugs Forecast by Region (2023-2028)
12.1.2 Global Gastrointestinal Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gastrointestinal Drugs Forecast by Type
12.7 Global Gastrointestinal Drugs Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Gastrointestinal Drugs Product Offered
13.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Gastrointestinal Drugs Product Offered
13.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Gastrointestinal Drugs Product Offered
13.3.3 Bayer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Gastrointestinal Drugs Product Offered
13.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Gastrointestinal Drugs Product Offered
13.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Gastrointestinal Drugs Product Offered
13.6.3 Teva Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Zeria (Tillotts)
13.7.1 Zeria (Tillotts) Company Information
13.7.2 Zeria (Tillotts) Gastrointestinal Drugs Product Offered
13.7.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Zeria (Tillotts) Main Business Overview
13.7.5 Zeria (Tillotts) Latest Developments
13.8 Perrigo
13.8.1 Perrigo Company Information
13.8.2 Perrigo Gastrointestinal Drugs Product Offered
13.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Perrigo Main Business Overview
13.8.5 Perrigo Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim Gastrointestinal Drugs Product Offered
13.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Purdue Pharma
13.10.1 Purdue Pharma Company Information
13.10.2 Purdue Pharma Gastrointestinal Drugs Product Offered
13.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Purdue Pharma Main Business Overview
13.10.5 Purdue Pharma Latest Developments
13.11 C.B. Fleet
13.11.1 C.B. Fleet Company Information
13.11.2 C.B. Fleet Gastrointestinal Drugs Product Offered
13.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 C.B. Fleet Main Business Overview
13.11.5 C.B. Fleet Latest Developments
13.12 Abbott
13.12.1 Abbott Company Information
13.12.2 Abbott Gastrointestinal Drugs Product Offered
13.12.3 Abbott Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Abbott Main Business Overview
13.12.5 Abbott Latest Developments
13.13 Jiangzhong
13.13.1 Jiangzhong Company Information
13.13.2 Jiangzhong Gastrointestinal Drugs Product Offered
13.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Jiangzhong Main Business Overview
13.13.5 Jiangzhong Latest Developments
13.14 Xian-Janssen
13.14.1 Xian-Janssen Company Information
13.14.2 Xian-Janssen Gastrointestinal Drugs Product Offered
13.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Xian-Janssen Main Business Overview
13.14.5 Xian-Janssen Latest Developments
14 Research Findings and Conclusion
Table 1. Gastrointestinal Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gastrointestinal Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Prescription Gastrointestinal Drug
Table 4. Major Players of OTC Gastrointestinal Drug
Table 5. Global Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Gastrointestinal Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Gastrointestinal Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Gastrointestinal Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Gastrointestinal Drugs Revenue by Application (2017-2022)
Table 13. Global Gastrointestinal Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Gastrointestinal Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Gastrointestinal Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Gastrointestinal Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Gastrointestinal Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Gastrointestinal Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Gastrointestinal Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Gastrointestinal Drugs Producing Area Distribution and Sales Area
Table 21. Players Gastrointestinal Drugs Products Offered
Table 22. Gastrointestinal Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gastrointestinal Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Gastrointestinal Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Gastrointestinal Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Gastrointestinal Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Gastrointestinal Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Gastrointestinal Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Gastrointestinal Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Gastrointestinal Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Gastrointestinal Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Gastrointestinal Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Gastrointestinal Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Gastrointestinal Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Gastrointestinal Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Gastrointestinal Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Gastrointestinal Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Gastrointestinal Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Gastrointestinal Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Gastrointestinal Drugs
Table 66. Key Market Challenges & Risks of Gastrointestinal Drugs
Table 67. Key Industry Trends of Gastrointestinal Drugs
Table 68. Gastrointestinal Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Gastrointestinal Drugs Distributors List
Table 71. Gastrointestinal Drugs Customer List
Table 72. Global Gastrointestinal Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Gastrointestinal Drugs Sales Market Forecast by Region
Table 74. Global Gastrointestinal Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Gastrointestinal Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Gastrointestinal Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Gastrointestinal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Gastrointestinal Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Gastrointestinal Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Gastrointestinal Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Gastrointestinal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Gastrointestinal Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Gastrointestinal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Gastrointestinal Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Gastrointestinal Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Gastrointestinal Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Gastrointestinal Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Gastrointestinal Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Gastrointestinal Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Gastrointestinal Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Gastrointestinal Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. AstraZeneca Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Gastrointestinal Drugs Product Offered
Table 94. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Sanofi Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Gastrointestinal Drugs Product Offered
Table 99. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Sanofi Main Business
Table 101. Sanofi Latest Developments
Table 102. Bayer Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer Gastrointestinal Drugs Product Offered
Table 104. Bayer Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Bayer Main Business
Table 106. Bayer Latest Developments
Table 107. Pfizer Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Gastrointestinal Drugs Product Offered
Table 109. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. GlaxoSmithKline Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. GlaxoSmithKline Gastrointestinal Drugs Product Offered
Table 114. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. GlaxoSmithKline Main Business
Table 116. GlaxoSmithKline Latest Developments
Table 117. Teva Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Teva Gastrointestinal Drugs Product Offered
Table 119. Teva Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Teva Main Business
Table 121. Teva Latest Developments
Table 122. Zeria (Tillotts) Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Zeria (Tillotts) Gastrointestinal Drugs Product Offered
Table 124. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Zeria (Tillotts) Main Business
Table 126. Zeria (Tillotts) Latest Developments
Table 127. Perrigo Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Perrigo Gastrointestinal Drugs Product Offered
Table 129. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Perrigo Main Business
Table 131. Perrigo Latest Developments
Table 132. Boehringer Ingelheim Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim Gastrointestinal Drugs Product Offered
Table 134. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
Table 137. Purdue Pharma Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Purdue Pharma Gastrointestinal Drugs Product Offered
Table 139. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Purdue Pharma Main Business
Table 141. Purdue Pharma Latest Developments
Table 142. C.B. Fleet Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. C.B. Fleet Gastrointestinal Drugs Product Offered
Table 144. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. C.B. Fleet Main Business
Table 146. C.B. Fleet Latest Developments
Table 147. Abbott Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Abbott Gastrointestinal Drugs Product Offered
Table 149. Abbott Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Abbott Main Business
Table 151. Abbott Latest Developments
Table 152. Jiangzhong Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Jiangzhong Gastrointestinal Drugs Product Offered
Table 154. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Jiangzhong Main Business
Table 156. Jiangzhong Latest Developments
Table 157. Xian-Janssen Basic Information, Gastrointestinal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Xian-Janssen Gastrointestinal Drugs Product Offered
Table 159. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. Xian-Janssen Main Business
Table 161. Xian-Janssen Latest Developments
List of Figures
Figure 1. Picture of Gastrointestinal Drugs
Figure 2. Gastrointestinal Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastrointestinal Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Gastrointestinal Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gastrointestinal Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Prescription Gastrointestinal Drug
Figure 10. Product Picture of OTC Gastrointestinal Drug
Figure 11. Global Gastrointestinal Drugs Sales Market Share by Type in 2021
Figure 12. Global Gastrointestinal Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Gastrointestinal Drugs Consumed in Chronic Gastritis
Figure 14. Global Gastrointestinal Drugs Market: Chronic Gastritis (2017-2022) & (K Units)
Figure 15. Gastrointestinal Drugs Consumed in Functional Dyspepsia
Figure 16. Global Gastrointestinal Drugs Market: Functional Dyspepsia (2017-2022) & (K Units)
Figure 17. Gastrointestinal Drugs Consumed in Peptic Ulcer
Figure 18. Global Gastrointestinal Drugs Market: Peptic Ulcer (2017-2022) & (K Units)
Figure 19. Gastrointestinal Drugs Consumed in Acute Gastroenteritis
Figure 20. Global Gastrointestinal Drugs Market: Acute Gastroenteritis (2017-2022) & (K Units)
Figure 21. Gastrointestinal Drugs Consumed in Other
Figure 22. Global Gastrointestinal Drugs Market: Other (2017-2022) & (K Units)
Figure 23. Global Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
Figure 24. Global Gastrointestinal Drugs Revenue Market Share by Application in 2021
Figure 25. Gastrointestinal Drugs Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Gastrointestinal Drugs Revenue Market Share by Company in 2021
Figure 27. Global Gastrointestinal Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Gastrointestinal Drugs Revenue Market Share by Geographic Region in 2021
Figure 29. Global Gastrointestinal Drugs Sales Market Share by Region (2017-2022)
Figure 30. Global Gastrointestinal Drugs Revenue Market Share by Country/Region in 2021
Figure 31. Americas Gastrointestinal Drugs Sales 2017-2022 (K Units)
Figure 32. Americas Gastrointestinal Drugs Revenue 2017-2022 ($ Millions)
Figure 33. APAC Gastrointestinal Drugs Sales 2017-2022 (K Units)
Figure 34. APAC Gastrointestinal Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Europe Gastrointestinal Drugs Sales 2017-2022 (K Units)
Figure 36. Europe Gastrointestinal Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Gastrointestinal Drugs Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Gastrointestinal Drugs Revenue 2017-2022 ($ Millions)
Figure 39. Americas Gastrointestinal Drugs Sales Market Share by Country in 2021
Figure 40. Americas Gastrointestinal Drugs Revenue Market Share by Country in 2021
Figure 41. United States Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Gastrointestinal Drugs Sales Market Share by Region in 2021
Figure 46. APAC Gastrointestinal Drugs Revenue Market Share by Regions in 2021
Figure 47. China Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Gastrointestinal Drugs Sales Market Share by Country in 2021
Figure 54. Europe Gastrointestinal Drugs Revenue Market Share by Country in 2021
Figure 55. Germany Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Gastrointestinal Drugs Revenue Market Share by Country in 2021
Figure 62. Egypt Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Gastrointestinal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Gastrointestinal Drugs in 2021
Figure 68. Manufacturing Process Analysis of Gastrointestinal Drugs
Figure 69. Industry Chain Structure of Gastrointestinal Drugs
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...